Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.5884
-6.19 %
$ 56.4 M
Market Cap
-2.56
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Assertio Holdings, Inc.
| Revenue | 125 M |
| Cost Of Revenue | 39.2 M |
| Gross Profit | 85.7 M |
| Operating Expenses | 110 M |
| Operating Income | -24.5 M |
| Other Expenses | -2.9 M |
| Net Income | -21.6 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | Dec-1997 | Dec-1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||||||
| Revenue | 125.0 | 152.1 | 156.2 | 111.0 | 106.3 | 229.5 | 311.8 | 380.7 | 455.9 | 342.7 | 390.4 | 134.2 | 90.8 | 133.0 | 80.8 | 57.7 | 34.8 | 65.6 | 9.6 | 4.4 | 0.2 | 1.0 | 1.7 | 3.7 | 1.8 | 0.1 | 0.8 | 0.6 | 0.3 |
| GROSS PROFIT | |||||||||||||||||||||||||||||
| Cost Of Revenue | 39.2 | 27.0 | 18.7 | 15.8 | 19.9 | 9.5 | 18.5 | 72.6 | 87.4 | 67.9 | 15.1 | 7.1 | 6.0 | 5.5 | 8.1 | 5.3 | 5.8 | 2.6 | 1.6 | 0.9 | 0 | 0 | 0 | 0 | (0.6) | (0.6) | (0.5) | (0.2) | 0 |
| Gross Profit | 85.7 | 125.0 | 137.5 | 95.2 | 86.4 | 220.0 | 293.3 | 308.1 | 368.5 | 274.8 | 375.2 | 127.1 | 84.8 | 127.4 | 72.7 | 52.5 | 29.1 | 63.0 | 8.0 | 3.5 | 0.2 | 1.0 | 1.7 | 3.7 | 2.3 | 0.8 | 1.3 | 0.8 | 0.3 |
| OPERATING INCOME | |||||||||||||||||||||||||||||
| Operating Expenses | 110.2 | 368.6 | 79.4 | 84.7 | 133.3 | 220.7 | 229.0 | 337.1 | 344.0 | 355.1 | 138.4 | 117.8 | 115.1 | 96.7 | 69.0 | 74.5 | 46.2 | 15.4 | 49.6 | 30.0 | 26.5 | 30.4 | 30.1 | 18.0 | 10.1 | 6.2 | 4.6 | 2.1 | 0.8 |
| Selling, General and Administrative Expenses | 75.1 | 69.7 | 46.8 | 56.6 | 104.3 | 108.9 | 119.2 | 195.7 | 204.5 | 199.4 | 121.1 | 105.2 | 97.6 | 81.5 | 48.9 | 40.2 | 26.4 | 26.7 | 22.7 | 11.6 | 5.2 | 3.5 | 5.4 | 2.5 | 2.0 | 1.9 | 2.0 | 1.0 | 0.4 |
| Research and Development Expenses | 3.8 | 2.8 | 0 | 0 | 4.2 | 10.1 | 8.0 | 38.6 | 32.6 | 72.4 | 7.1 | 8.1 | 15.5 | 15.2 | 20.1 | 34.3 | 27.3 | 23.3 | 26.9 | 18.4 | 21.4 | 26.9 | 24.7 | 15.5 | 7.5 | 3.7 | 2.1 | 0.9 | 0.4 |
| Operating Income | (24.5) | (243.5) | 57.8 | 9.4 | (46.9) | 3.2 | 43.7 | (42.2) | 24.5 | (50.4) | 236.8 | 9.3 | (30.4) | 70.7 | 3.6 | (22.1) | (17.1) | 47.5 | (41.6) | (26.5) | (26.3) | (29.4) | (28.4) | (14.3) | (7.7) | (5.5) | (3.3) | (1.3) | (0.5) |
| PRE-TAX INCOME | |||||||||||||||||||||||||||||
| Interest Income Expense | 2.6 | 3.4 | 8.0 | 10.2 | 15.9 | 58.4 | 68.9 | 73.6 | 83.7 | 73.4 | 23.9 | 4.5 | 39 K | 0.1 | 0.6 | 1.0 | 0.6 | 0 | 0 | 0.5 | 0.9 | 0.9 | 0.7 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 2.9 | (10.5) | (26.6) | (10.0) | 36.6 | (28.1) | (5.7) | (61.7) | (89.0) | (72.8) | (23.7) | (4.7) | 0.5 | 0.4 | 0.3 | 49 K | 1.8 | 39.6 | 2.0 | 2.0 | (0.4) | 5.36 K | 15.6 | (3.2) | (2.2) | (12.0) | 0.5 | 0 | 0.5 |
| Pre-Tax Income | (21.5) | (254.1) | 31.2 | (0.6) | (45.5) | (222.5) | 38.0 | (103.9) | (64.5) | (123.2) | 213.1 | 4.6 | (29.9) | 71.1 | 3.9 | (22.0) | (15.3) | 49.8 | (39.6) | (24.5) | (26.8) | (29.4) | (12.9) | (17.5) | (9.9) | (17.5) | (2.8) | 0 | 0 |
| NET INCOME | |||||||||||||||||||||||||||||
| Tax Provision | 52 K | 77.9 | (78.5) | 0.7 | (17.4) | (5.3) | 1.1 | (1.4) | 24.2 | (47.5) | 81.3 | (38.7) | 91 K | 0.4 | 4 K | 15 K | 1 K | 0.6 | 82.5 K | (2.0) | 99 K | 0.6 | (17.4) | 0.1 | 2.0 | 11.7 | (0.5) | 100 K | 0.5 |
| Net Income | (21.5) | (331.9) | 109.6 | (1.3) | (28.1) | (217.2) | 36.9 | (102.5) | (88.7) | (75.7) | 131.8 | 43.3 | (29.8) | 70.7 | 3.9 | (22.0) | (15.3) | 49.2 | (39.7) | (24.5) | (26.9) | (30.0) | (13.5) | (17.6) | (9.7) | (17.2) | (2.8) | (1.2) | (0.5) |
| EPS | 0.23 | 4.67 | 2.33 | 0.0297 | 1.07 | 12.3 | 2.31 | 6.54 | 5.8 | 5.04 | 9.04 | 3.04 | 2.13 | 5.2 | 0.28 | 1.71 | 1.25 | 4.24 | 3.82 | 2.46 | 3.1 | 4.91 | 3.69 | 6.89 | 5.29 | 10.6 | 1.77 | 1.08 | 0.48 |